Insights

News

April 14, 2025

Two Recent Federal Circuit Decisions Provide Important Guidance on the Economic Prong of the Domestic Industry Requirement in Section 337 Investigations.

March 20, 2025

The Award of “Defendant’s Profits” Under 15 U.S.C. § 1117(a) of the Lanham Act is Confined to Profits Ascribable to the Named Defendant Itself

March 20, 2025

Is a Voluntary Dismissal Without Prejudice Under Rule 41(a) of the Federal Rules of Civil Procedure a “Final Proceeding” Under Rule 60(b)?

January 22, 2025

Federal Circuit Addresses Functionality and Unclean Hands in Decision Affirming Cancellation of Trademarks for the Pink Color of Ceramic Hip Implant Components.

December 23, 2024

When Attorneys’ Fees and Costs Under 35 U.S.C. § 285 are Awarded to a Party, Can Additional Sanctions, Like Deterrence Sanctions, Be Imposed Under the Court’s Inherent Power?

November 8, 2024

A Party’s False Advertising Statements that it Possesses a Patent on a Product Feature May Give Rise to a Cause of Action Under Section 43 of the Lanham Act
Nixon & Vanderhye is growing again! We are very pleased to welcome two highly skilled IP attorneys as shareholders in the life sciences, pharmaceutical, chemical, and materials science areas. 

September 27, 2024

Third and Ninth Circuit Appellate Courts Provide Guidance on Applying Brulotte and Kimble to Post-Patent Expiration Royalty Payment Agreements

July 12, 2024

FEDERAL CIRCUIT EXPLAINS THE PRELIMINARY INJUNCTION ANALYSIS FOR A CLAIM BROUGHT UNDER THE DEFEND TRADE SECRETS ACT

July 12, 2024

U.S. SUPREME COURT DEEP-SIXES “CHEVRON DEFERENCE”

April 25, 2024

Federal Circuit Provides Guidance for Assessing the “Materiality” and “Intent” Requirements of Inequitable Conduct, Addresses Serial Misconduct

April 19, 2024

Scientific Games Loses Bid to End Walker Process Fraud/Sham Litigation Antitrust Action on Summary Judgment for the Second Time in Ruling that Provides Caveats on IDS Submissions to the USPTO

How can we help you?